Building...
Holistic..
Healthcare.
Brands

""America BioHealth is not just a healthcare provider; We empower specialized medical leaders to run independent mission-driven life sciences brands, supported by the ABH capital and protocol backbone while bridging the gap between profit and purpose in the healthcare sector through a collection of clinical breakthroughs."

By operating our flagship BioDental clinics independently from our Social Franchising Lab, we ensure that each brand has the focus to move fast, while ABH provides the rigorous capital allocation to make them prosper. We are making big bets on human health, and we are just getting started."

Operating in the robinhood economy as a new hybrid organization—part private equity foundation, part business deal venture capital—we challenge the status quo of modern healthcare delivery, which we view as fragmented and inequitable... Our philosophy is grounded in the conviction that the "serious social problems" plaguing global health today are the direct result of structural failures within the three dominant silos of the current conventional care ecosystem: Public (government-run), Private (independent), Corporatized (consolidated systems).

By positioning ourselves outside of these traditional categories, we aim to create a "third way" that combines the sustainability of capitalism with the compassion of humanitarian aid. Our central strategic innovation is the implementation of a Healthcare Social Franchise Business Model. Unlike traditional charities that rely on endless fundraising, or corporations that prioritize shareholder returns above patient outcomes, we utilize a franchising framework to replicate successful healthcare solutions. This model is designed to scale "biomedical-class care" efficiently across underserved regions.

By standardizing operations, branding, and quality control—much like a commercial franchise—we lower the barriers to entry for healthcare providers while ensuring that high-quality care reaches the populations that need it most, particularly in the realm of "applied oral healing." To execute our vision, we have established a supportive ecosystem built on four operational pillars: Social Impact, Entrepreneurship, Knowledge Hubs, and Co-Working Spaces.

A tangible example of this ecosystem is Cyclops Hub, an BioSphere based co-working space located in Costa Rica. This hub serves as a physical cluster for mission-driven entrepreneurs and social organizations, fostering a community where "rational lo-tech solutions" can be developed and refined. This collaborative environment is critical to our strategy, as it creates a "safe harbor" for innovation that might otherwise be stifled by the high costs and complexities of the traditional medical industry. A key differentiator in our clinical approach is the focus on "root cause" diagnostics and "rational lo-tech" interventions.

Rather than pursuing the most expensive, high-tech treatments that are often inaccessible to the global majority, we champion technology that simplifies workflows and mitigates complexity. We believe that by equipping practitioners with tools to identify the source of disease more accurately, we can reduce the overall burden on the healthcare system.

This "biomedical social science" approach is not just about treating symptoms but about fundamentally reshaping the practitioner-patient relationship to be more efficient, effective, and socially responsible. Ultimately, we view ourselves as a catalyst for a "global society" where health equity is achieved through smart business architecture rather than just goodwill.

By investing in deal structures that prioritize "optimal social impact" alongside financial sustainability, we seek to overcome the entrepreneurial setbacks that often doom and gloom small healthcare ventures. Our model offers a blueprint for co-engaging in a social enterprise, proving that it is possible to maintain a bottom line while aggressively tackling healthcare disenfranchisement and improving the quality of life for communities worldwide.

For over a decade, America BioHealth (ABH) has operated at the intersection of clinical excellence and systemic reform. By leveraging a deep well of holistic health knowledge and insights derived from ten years of outstanding healthcare business building, we have identified the critical gaps in traditional medical delivery. We aren't just participants in the industry; we are architects of its evolution. Our foundation is built on the belief that a global society is only as strong as its health infrastructure, and we contribute to that foundation by re-imagining how care is distributed.

Today, we are moving beyond traditional models to invest in and build new socially franchised healthcare businesses. These models are engineered to do more than generate revenue; they are designed to have a measurable, positive impact on both society and the environment. By utilizing "rational lo-tech" innovations and standardized clinical protocols, we reduce the heavy carbon footprint and high-waste outputs of "big-box" corporate medicine, proving that sustainable business architecture is the key to both ecological and societal health.

The core of our mission is inclusivity. We help people from all walks of life, age groups, and backgrounds to address pressing global health concerns. Through the social franchising business model, we democratize access to high-tier biomedical and dental care. This model acts as a vehicle for "Inclusive Growth," ensuring that life-saving innovations are not restricted to wealthy urban centers but are instead made accessible to those born into more humble circumstances across the globe.

We build on this foundation by thinking and acting with radical responsibility. Whether dealing with our investment partners, our staff, or the communities in which we live and work and play, we prioritize ethical governance. Our framework is built on the principles of Transparency, Participation, and Accountability (TPA). This ensures that every investment we make is ethically sound and that our growth never comes at the expense of the trust we have cultivated over the last decade.

Strategic partnerships are the lifeblood of our expansion. We create collaborations that put the requirements of our partners and patients first, sharing our own resources and "Knowledge Hubs" to ensure mutual success. By fostering a "Safe Harbor" for mission-driven entrepreneurs and practitioners, we allow for the transfer of expertise that is often hoarded in the private sector. This spirit of shared prosperity is what allows our decentralized network to remain unified and effective.

Ultimately, ABH is creating a prosperous, resilient global healthcare ecosystem where smart business architecture and humanitarian purpose are perfectly aligned. We are not just treating symptoms; we are building a new blueprint for global society. As we continue to scale our socially franchised models, we remain dedicated to the idea that health equity should be the global standard, ensuring a future where quality care is a universal reality rather than a localized privilege.

At America BioHealth (ABH), governance is not a set of static mandates but a dynamic moral compass that guides every strategic move. We ensure our operational DNA is rooted in Transparency, Participation, and Accountability (TPA), creating a framework where decisions are deeply conscious of their human impact. From the clinicians on the front lines to patients in underserved regions, our ethical architecture ensures that expansion is never predatory, but always restorative and principled.

We reject the outdated belief that social impact and financial performance are a zero-sum game. Our "Third Way" strategy proves that smart business architecture can simultaneously generate robust investor returns and lasting humanitarian contributions. By standardizing and replicating "rational lo-tech" clinical solutions, we lower the barrier to entry for practitioners and the cost of care for patients, creating a high-volume ecosystem that rewards stakeholders at every level.

Inclusivity serves as the primary engine of our value creation, specifically targeting the "Inclusive Growth" often ignored by traditional corporatized medicine. We transform high-tier biomedical and dental innovations into scalable franchises, turning systemic disenfranchisement into an opportunity for communal stability. We don’t just enter markets; we build the foundations for a resilient global society where health equity is the standard rather than the exception.

ABH acts as a safe harbor for mission-driven investors and entrepreneurs who refuse to choose between their conscience and their capital. By prioritizing the requirements of the local community first, we share our extensive "Knowledge Hubs" and holistic insights to ensure long-term stability. This collaborative spirit allows our decentralized network to remain unified, ensuring that expertise is shared rather than hoarded.

Ultimately, we are proving that a steadfast commitment to humanitarian purpose is the most effective way to build a sustainable, profitable, and ethically sound healthcare future. We are not just treating symptoms; we are building a new blueprint for global society. As we scale our socially franchised models, we remain dedicated to the idea that quality care is a universal reality, ensuring a future where business success and human well-being are perfectly aligned.

As a regional, science-led biomedical enterprise, we are dedicated to developing innovative services that impact billions of lives globally. We operate with a dual responsibility: delivering high-quality care to our communities while maintaining a profit-making structure that ensures financial growth and stakeholder accountability. By integrating rigorous strategic planning, we outline the actionable steps necessary to achieve our long-term objectives, ensuring every move is backed by data and purpose.

Our methodology relies on a comprehensive approach that measures both performance outcomes and operational costs with precision. This data-driven strategy allows us to foster continuous, results-oriented innovation across the entire healthcare continuum. By maintaining this balance, we ensure that our discoveries are not just scientifically sound but also operationally sustainable, providing a foundation for consistent excellence in a competitive global landscape.

To secure the enduring success of our organizations and the communities we serve, we anchor all activities to the specific needs of our medical consumers. This consumer-centric model enables us to shape population health and achieve business success simultaneously by identifying untapped markets and developing specialized services. We build the enabling systems that serve as the lifeblood of our global brands, ensuring they remain resilient and responsive to the evolving demands of the healthcare industry.

Navigating the complexity of modern healthcare requires a deep commitment to social responsibility and ethical transparency. We believe in the power of communicating our mission in a way that inspires and aligns our diverse, multi-disciplinary workforce toward a singular goal. This clarity allows our team to act in the best interests of our patients and global society, fostering a culture where shared purpose drives sustainable innovation and communal prosperity.

Our strategic alliances and partnerships serve as a primary engine advancing America BioHealth's mission to fundamentally change the course of health and healthcare delivery. By implementing shared ideas, industry-leading best practices, and innovative human resource strategies, we deploy robust systems designed to have a substantial, lasting impact on individuals and diverse populations across the globe.

Each strategic partnership we cultivate deepens our collective research capabilities, effectively lowers operational costs, optimizes internal processes, and expands our reach into new markets. These collaborations allow us to proactively shape the future by co-creating a wealth of guidance and support that empowers our healthcare leaders and investors to become more resilient. By leveraging complementary strengths, technical skills, and global networks, we are uniquely positioned to tackle the most complex issues facing the industry today.

We clearly recognize the significant financial value that strategic partnerships bring to our organizations. Consequently, we provide a broad range of alliances within the wider health systems of life sciences, academia, and clinical medicine to help drive sustainable growth across the business, the local community, and the entire region. This interconnected approach ensures that our "Third Way" strategy remains a safe harbor for mission-driven entrepreneurs and investors alike.

We possess a deep understanding of the critical challenges and priorities currently facing patient safety, quality of care, rising costs, and population health. To address these, we collaborate on rigorous research and development through a continuous cycle of coaching, testing, and learning. This allows us to combine our expertise and core competencies to create new models that deliver superior, more affordable healthcare services while simultaneously optimizing our day-to-day operations and maximizing cost savings.

America BioHealth originated in 2013 as a socially conscious humanitarian mission driven by the personal journey of Victor Ronald K.M. (Víck), a young Polish-Austrian refugee. His quest for "self-care" led him to acquire highly specialized and elusive biomedical equipment, specifically designed for the safe extraction of toxic, mercury-laden amalgam fillings. This investment was fueled by a vision to help protect patients, clinicians, and staff from the environmental and physiological hazards of heavy metal exposure.

The organization’s foundational protocol was developed entirely in-house, enabling Víck to achieve his "moonshot" dream of democratizing mercury-free dentistry within Costa Rica. Working one-on-one with a newly trained family dentist in the small town of San Pablo, Heredia, he proved that a boutique, safety-first approach could yield transformative results. The brand’s first chief clinician, Dr. Benavides—a dual U.S. and Costa Rican citizen—immediately recognized the necessity of evolving oral healthcare sciences and championed the cause from its inception.

By 2014, the brand evolved into the regional market leader for holistic and alternative oral healthcare. Under Víck’s leadership, the organization established Central America’s first formal holistic and biological dental practice, attracting a conscious community of both international medical tourists and local residents. This period marked the company's transition from a local effort to a sophisticated clinical destination, setting a new benchmark for biological dental excellence in the region.

Innovation remained the lifeblood of the company as it introduced five revolutionary pillars to the Costa Rican market: safe amalgam removal, oxygen ozone therapy, hydro-air abrasion, biomimetic principles, and the exclusive use of biocompatible materials. These core services effectively merged high-tech surgical precision with biological harmony. This "Third Way" of practicing dentistry allowed practitioners to achieve clinical excellence while ensuring the systemic wellness of the patient.

A significant milestone occurred in the spring of 2015 when the organization relocated to the prestigious CIMA International Hospital grounds. Situated within an elite commercial and business district, the move symbolized the brand's arrival as a major player in the global medical landscape. This location provided the professional infrastructure necessary to scale their science-led, patient-focused approach to a broader audience of health-conscious consumers.

To maintain a competitive edge in global innovation, Victor executed a bold strategic move by sending his clinical partners to the Zimmer-Biomet Institute in Parsippany, New Jersey. This advanced training in oral surgery and aesthetic implant dentistry was critical for mastering the placement of 100% biocompatible dental implants. By prioritizing the body’s physiological integrity over mere aesthetics, the team solidified their reputation for uncompromising clinical standards.

By the end of 2015, Victor assumed the presidency of what had become the definitive go-to-market leader for primary, complementary, and alternative oral healthcare in Central America. The BioDental family of companies nurtured a loyal following of conscious individuals who valued the brand’s unique blend of technology and biology. This period of rapid growth validated the organization’s specialized business architecture as a resilient and profitable model.

America BioHealth S.A. was formally incorporated in 2018 as the parent company for all BioDental holdings, marking the transition from a clinical practice to a diversified healthcare enterprise. The early introduction of the five revolutionary pillars served as the disruption that transformed the clinic into a scalable "Knowledge Hub." This shift bridged the gap between clinical practice and technological advancement, laying the groundwork for the world’s first holistic and biological dental clinical service franchise.

Today, this robust foundation has allowed America BioHealth (ABH) to evolve into a pioneering private equity and venture capital fund. The company is now uniquely positioned to secure and align investments across the frontiers of blockchain, Decentralized Autonomous Organizations (DAOs), and Web3 technology assets. By merging a decade of healthcare expertise with decentralized finance, ABH is architecting a future where mission-driven capital fuels a resilient and transparent global health ecosystem.

The BioHealth Foundation is dedicated to addressing the critical unmet healthcare needs of underserved populations by advancing scalable social franchise models rooted in socially minded entrepreneurship. We operate on the core belief that a healthier world requires more than isolated medical services; it demands a collaborative ecosystem built on strategic partnerships. Through targeted grant-gifting and capacity-building support for aligned partners and investors, we strive to make a transformative contribution to local communities with initiatives designed to create a permanent, positive difference.

Our work rests upon a robust foundation and a proven social entrepreneurship narrative that has already improved the lives of thousands globally. As the dedicated philanthropic arm of the America BioHealth commercial enterprise in Costa Rica, the foundation champions world-class biomedical research and innovation. We achieve this by identifying and supporting qualified social entrepreneurs who are committed to operating within the primary, complementary, and alternative oral healthcare sectors.

We are steadfast in our mission to improve lives, healthcare systems, and society at large by focusing on high-impact entrepreneurial opportunities that empower individuals and communities to thrive. The BioHealth Foundation remains committed to communal prosperity by fostering social enterprise businesses that streamline and support the procurement of premium, biomedical-class care for those who need it most. By lowering the barriers to entry for practitioners, we ensure that high-tier health services are no longer a luxury but a community standard.

Integrating the transparency of decentralized finance with our foundational excellence, the foundation is now pioneering a new frontier in the healthcare industry. By leveraging our "Knowledge Hubs" and the five revolutionary pillars of biological dentistry, we are creating a symbiotic relationship between physical health and digital asset innovation. This integration allows the foundation to track impact with unprecedented accuracy, ensuring that every dollar spent is optimized for maximum human benefit.

Our Web3 and blockchain initiatives serve as the financial and operational backbone for our social franchising clinics. This ensures that every investment is not only secure and transparent but also directly contributes to the expansion of health equity across the globe. Through the use of Decentralized Autonomous Organizations (DAOs), we empower our stakeholders—from clinicians to investors—to have a direct voice in the governance and strategic direction of the organization, fostering a truly democratic approach to philanthropy.

Ultimately, this alignment of private equity and Web3 technology allows us to scale our humanitarian mission at an unprecedented pace. We are proving that the future of medicine is not just biological, but decentralized, ensuring that high-impact healthcare remains accessible, accountable, and driven by a shared vision of global well-being. By merging these digital assets with clinical practice, we are building a resilient infrastructure where business success and humanitarian impact are one and the same.

"At America BioHealth, we believe in the ambition of meaningful bets and that the greatest risk in healthcare is not being bold enough."

While the traditional reductionist incumbents focus on the safety of incrementalism, ABH Labs is designed to take meaningful bets on the future of human longevity. We recognize that some of our pursuits—such as borderless teledentistry through Virtual Dental Canada or maternal-biological harmony via Costa Rican Doula—may seem "crazy" to those entrenched in 20th-century models. However, we are not interested in the status quo; we are interested in the next hundred years of human health.

Social Franchising: Our Global Moonshot

Our most ambitious "Moonshot" is not a piece of hardware, but a new model of distribution: Social Franchising. We view Social Franchising as the ultimate vehicle for longevity. By "gifting" our proprietary biomedical protocols and high-fidelity "Business-in-a-Box" systems to local entrepreneurs, we are decentralizing elite healthcare. We are betting that:

• Independence Trumps Centralization: Local clinician-owners, empowered by ABH resources, will outperform monolithic corporate chains.

• Biocompatibility is Universal: The demand for non-toxic, biological protocols is a global tidal wave that traditional insurance-based models are failing to meet.

• Longevity is a Right, Not a Luxury: By scaling these franchises, we drive down the cost of entry for life-extending biological care.

Investing in the "Unconventional"

Through the ABH Partners Venture Capital & Private Equity Fund, we provide the financial "fuel" for these moonshots. We intentionally allocate capital toward areas that traditional healthcare incumbents find uncomfortable. We aren't just building clinics; we are building the infrastructure for a future where chronic inflammation is rare and biological integrity is the standard.

"If you're not doing some things that are crazy, then you're doing the wrong things." — This is the spirit of the ABH Innovation Lab. We invite those who see the horizon differently to join us.